{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:55:16Z","timestamp":1791356116569,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejpb.2012.02.008","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T07:37:01Z","timestamp":1331019421000},"page":"102-112","source":"Crossref","is-referenced-by-count":105,"title":["Paclitaxel-loaded ethosomes\u00ae: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses"],"prefix":"10.1016","volume":"81","author":[{"given":"Donatella","family":"Paolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Celia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Trapasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felisa","family":"Cilurzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2012.02.008_b0005","unstructured":"Skin cancer. National Cancer Institute. <http:\/\/www.cancer.gov\/cancertopics\/types\/skin> (accessed 4.03.10)."},{"key":"10.1016\/j.ejpb.2012.02.008_b0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-4632.2007.03166.x","article-title":"Actinic keratosis","volume":"46","author":"Rossi","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000254893","article-title":"Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses","volume":"220","author":"Ulrich","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.ejpb.2012.02.008_b0025","first-page":"39","article-title":"Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer","volume":"3","author":"Cohen","year":"2010","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0030","first-page":"864","article-title":"Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments","volume":"9","author":"Han","year":"2010","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3346\/jkms.2010.25.6.924","article-title":"Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006","volume":"25","author":"Kim","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ejpb.2012.02.008_b0040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-4632.2004.02124.x","article-title":"Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians","volume":"43","author":"Halpern","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0190-9622(99)70526-8","article-title":"Destructive procedures are the standard of care for treatment of actinic keratoses","volume":"40","author":"Feldman","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157488706775246166","article-title":"Topical therapy for actinic keratoses: current and evolving therapies","volume":"1","author":"Weinberg","year":"2006","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.ejpb.2012.02.008_b0055","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-1097.2007.00276.x","article-title":"Photodynamic therapy in the treatment of actinic keratosis","volume":"84","author":"Stritt","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0060","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1158\/0008-5472.CAN-09-4303","article-title":"The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2012.02.008_b0065","first-page":"29","article-title":"Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses","volume":"8","author":"Resnick","year":"2009","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/09546630902789326","article-title":"Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders","volume":"20","author":"Moore","year":"2009","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.ejpb.2012.02.008_b0075","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.4076\/1757-1626-2-6946","article-title":"Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report","volume":"2","author":"Makdsi","year":"2009","journal-title":"Cases J."},{"key":"10.1016\/j.ejpb.2012.02.008_b0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/jps.22370","article-title":"Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel","volume":"100","author":"Hosmer","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.02.008_b0085","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jps.20140","article-title":"Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel","volume":"93","author":"Panchagnula","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2012.02.008_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.toxlet.2004.08.003","article-title":"Cremophor EL augments the cytotoxicity of hydrogen peroxide in lymphocytes dissociated from rat thymus glands","volume":"154","author":"Iwase","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejpb.2012.02.008_b0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jid.5700485","article-title":"Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats","volume":"127","author":"Khandavilli","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i4.10","article-title":"Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges","volume":"26","author":"Singh","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2012.02.008_b0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/17425247.5.7.737","article-title":"Colloidal carriers for the enhanced delivery through the skin","volume":"5","author":"Cosco","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2012.02.008_b0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes \u2013 novel vesicular carriers for enhanced delivery: characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2012.02.008_b0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol\u2013transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2003","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2012.02.008_b0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1166\/jbn.2010.1152","article-title":"Drug delivery applications with ethosomes","volume":"6","author":"Ainbinder","year":"2010","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2005.04.007","article-title":"Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers","volume":"106","author":"Paolino","year":"2005","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2012.02.008_b0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2003.10.014","article-title":"Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier","volume":"94","author":"Godin","year":"2004","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2012.02.008_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i1.20","article-title":"Ethosomes: new prospects in transdermal delivery","volume":"20","author":"Godin","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2012.02.008_b0140","first-page":"964","article-title":"Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low-calcium-grown human epidermal carcinoma cells: involvement of translocation and down-regulation of protein kinase C","volume":"48","author":"Kitajima","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2012.02.008_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/156800909787580944","article-title":"Lipoamino acid prodrugs of paclitaxel: synthesis and cytotoxicity evaluation on human anaplastic thyroid carcinoma cells","volume":"9","author":"Pignatello","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejpb.2012.02.008_b0150","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.1963.01590240026005","article-title":"Preparation of isolated sheets of human stratum corneum","volume":"88","author":"Kligman","year":"1963","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejpb.2012.02.008_b0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-5173(00)00358-6","article-title":"In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents","volume":"199","author":"Saija","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.008_b0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10611869609046267","article-title":"Application of liposomes as potential cutaneous drug delivery. In vitro and in vivo investigation with radioactively labelled vesicles","volume":"4","author":"Fresta","year":"1996","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2012.02.008_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2011.03.068","article-title":"Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin","volume":"412","author":"Manconi","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.008_b0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cyto.990140502","article-title":"DNA cytometry consensus conference","volume":"14","author":"Hedley","year":"1993","journal-title":"Cytometry"},{"key":"10.1016\/j.ejpb.2012.02.008_b0175","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0142-9612(00)00063-6","article-title":"Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes","volume":"21","author":"Dayan","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2012.02.008_b0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1567201054367931","article-title":"Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity","volume":"2","author":"Godin","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2012.02.008_b0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2007.02.011","article-title":"Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation","volume":"338","author":"Yang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2012.02.008_b0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-3659(99)00166-2","article-title":"Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes","volume":"63","author":"Crosasso","year":"2000","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2012.02.008_b0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nano.2009.04.003","article-title":"Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response","volume":"6","author":"Mishra","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2012.02.008_b0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.colsurfb.2009.10.009","article-title":"Polydiacetylene vesicles as a novel drug sustained-release system","volume":"76","author":"Guo","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2012.02.008_b0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/bp060208+","article-title":"Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers","volume":"23","author":"Li","year":"2007","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ejpb.2012.02.008_b0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2007.05.011","article-title":"Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome","volume":"120","author":"Yang","year":"2007","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2012.02.008_b0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejpb.2009.07.011","article-title":"Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior","volume":"73","author":"Fang","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.02.008_b0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10717540500176910","article-title":"Testosterone ethosomes for enhanced transdermal delivery","volume":"12","author":"Ainbinder","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2012.02.008_b0225","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2007.03.007","article-title":"Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery","volume":"67","author":"Dubey","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2012.02.008_b0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425247.4.6.579","article-title":"Vesicles as tools for the modulation of skin permeability","volume":"4","author":"Dubey","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2012.02.008_b0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1208\/pt0804111","article-title":"Formulation and evaluation of ethosomes for transdermal delivery of lamivudine","volume":"8","author":"Jain","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2012.02.008_b0240","first-page":"2951","article-title":"Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells","volume":"29","author":"Kov\u00e1r","year":"2009","journal-title":"Anticancer Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641112000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T13:56:33Z","timestamp":1543154193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641112000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0939641112000471"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2012.02.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}